Specifically, the inhibition of CypB’s PPIase activity can regulate adipocyte differentiation and lipid metabolism, providing a foundational basis for developing new therapeutic strategies for obesity. This evidence concerns the gene PPIB and obesity due to melanocortin 4 receptor deficiency.